666 related articles for article (PubMed ID: 16204462)
1. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells.
Aninat C; Piton A; Glaise D; Le Charpentier T; Langouët S; Morel F; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2006 Jan; 34(1):75-83. PubMed ID: 16204462
[TBL] [Abstract][Full Text] [Related]
2. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.
Guillouzo A; Corlu A; Aninat C; Glaise D; Morel F; Guguen-Guillouzo C
Chem Biol Interact; 2007 May; 168(1):66-73. PubMed ID: 17241619
[TBL] [Abstract][Full Text] [Related]
3. Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.
Anthérieu S; Chesné C; Li R; Camus S; Lahoz A; Picazo L; Turpeinen M; Tolonen A; Uusitalo J; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2010 Mar; 38(3):516-25. PubMed ID: 20019244
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies.
Kanebratt KP; Andersson TB
Drug Metab Dispos; 2008 Jul; 36(7):1444-52. PubMed ID: 18385292
[TBL] [Abstract][Full Text] [Related]
5. HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.
Kanebratt KP; Andersson TB
Drug Metab Dispos; 2008 Jan; 36(1):137-45. PubMed ID: 17954527
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
Westerink WM; Schoonen WG
Toxicol In Vitro; 2007 Dec; 21(8):1581-91. PubMed ID: 17637504
[TBL] [Abstract][Full Text] [Related]
7. Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells.
Lambert CB; Spire C; Claude N; Guillouzo A
Toxicol Appl Pharmacol; 2009 Feb; 234(3):345-60. PubMed ID: 19084549
[TBL] [Abstract][Full Text] [Related]
8. Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line.
Le Vee M; Jigorel E; Glaise D; Gripon P; Guguen-Guillouzo C; Fardel O
Eur J Pharm Sci; 2006 May; 28(1-2):109-17. PubMed ID: 16488578
[TBL] [Abstract][Full Text] [Related]
9. Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression.
Sugatani J; Wada T; Osabe M; Yamakawa K; Yoshinari K; Miwa M
Drug Metab Dispos; 2006 Oct; 34(10):1677-87. PubMed ID: 16815962
[TBL] [Abstract][Full Text] [Related]
10. Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1.
Braeuning A; Sanna R; Huelsken J; Schwarz M
Drug Metab Dispos; 2009 May; 37(5):1138-45. PubMed ID: 19237511
[TBL] [Abstract][Full Text] [Related]
11. [New perspectives in the use of human hepatocytes in the preclinical drug development process].
Guillouzo A
Ann Pharm Fr; 2008; 66(5-6):288-95. PubMed ID: 19061728
[TBL] [Abstract][Full Text] [Related]
12. Functional expression, inhibition and induction of CYP enzymes in HepaRG cells.
Turpeinen M; Tolonen A; Chesne C; Guillouzo A; Uusitalo J; Pelkonen O
Toxicol In Vitro; 2009 Jun; 23(4):748-53. PubMed ID: 19328226
[TBL] [Abstract][Full Text] [Related]
13. Long-term functional stability of human HepaRG hepatocytes and use for chronic toxicity and genotoxicity studies.
Jossé R; Aninat C; Glaise D; Dumont J; Fessard V; Morel F; Poul JM; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2008 Jun; 36(6):1111-8. PubMed ID: 18347083
[TBL] [Abstract][Full Text] [Related]
14. Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties.
Wilkening S; Stahl F; Bader A
Drug Metab Dispos; 2003 Aug; 31(8):1035-42. PubMed ID: 12867492
[TBL] [Abstract][Full Text] [Related]
15. Human hepatoma HepaRG cell line engraftment in severe combined immunodeficient × beige mice using mouse-specific anti-Fas antibody.
Jiang L; Li JG; Lan L; Wang YM; Mao Q; You JP
Transplant Proc; 2010 Nov; 42(9):3773-8. PubMed ID: 21094855
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous measurement of 23 isoforms from the human cytochrome P450 families 1 to 3 by quantitative reverse transcriptase-polymerase chain reaction.
Girault I; Rougier N; Chesné C; Lidereau R; Beaune P; Bieche I; de Waziers I
Drug Metab Dispos; 2005 Dec; 33(12):1803-10. PubMed ID: 16135659
[TBL] [Abstract][Full Text] [Related]
17. Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
Westerink WM; Schoonen WG
Toxicol In Vitro; 2007 Dec; 21(8):1592-602. PubMed ID: 17716855
[TBL] [Abstract][Full Text] [Related]
18. Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction.
Hariparsad N; Carr BA; Evers R; Chu X
Drug Metab Dispos; 2008 Jun; 36(6):1046-55. PubMed ID: 18332078
[TBL] [Abstract][Full Text] [Related]
19. Infection of a human hepatoma cell line by hepatitis B virus.
Gripon P; Rumin S; Urban S; Le Seyec J; Glaise D; Cannie I; Guyomard C; Lucas J; Trepo C; Guguen-Guillouzo C
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15655-60. PubMed ID: 12432097
[TBL] [Abstract][Full Text] [Related]
20. Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions.
Lambert CB; Spire C; Renaud MP; Claude N; Guillouzo A
Toxicol In Vitro; 2009 Apr; 23(3):466-75. PubMed ID: 19159669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
